Cell Line : ASKA-SS
Cellosaurus Index : CVCL_6C43
Cellosaurus ID : ASKA-SS
CTRP2 Name
: ASKA
Cancer Type : ns
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| ASKA-SS | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| ASKA-SS | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| ASKA-SS | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| ASKA-SS | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| ASKA-SS | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD-K01737880 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| ASKA-SS | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K11533227 | CTRP2 | 0.0020 | 33.0000 |
|
| ASKA-SS | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| ASKA-SS | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| ASKA-SS | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K30748066 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| ASKA-SS | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| ASKA-SS | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD-K41597374 | CTRP2 | 0.0020 | 67.0000 |
|
| ASKA-SS | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| ASKA-SS | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| ASKA-SS | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| ASKA-SS | Ch-55 | CTRP2 | 0.0020 | 17.0000 |
|
| ASKA-SS | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| ASKA-SS | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| ASKA-SS | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| ASKA-SS | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| ASKA-SS | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| ASKA-SS | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| ASKA-SS | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| ASKA-SS | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| ASKA-SS | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | GSK4112 | CTRP2 | 0.0081 | 66.0000 |
|
| ASKA-SS | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| ASKA-SS | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ASKA-SS | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| ASKA-SS | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| ASKA-SS | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| ASKA-SS | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | MIRA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| ASKA-SS | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| ASKA-SS | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| ASKA-SS | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| ASKA-SS | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| ASKA-SS | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| ASKA-SS | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| ASKA-SS | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| ASKA-SS | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | palmostatin B | CTRP2 | 0.0041 | 66.0000 |
|
| ASKA-SS | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| ASKA-SS | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| ASKA-SS | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| ASKA-SS | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | purmorphamine | CTRP2 | 0.0046 | 75.0000 |
|
| ASKA-SS | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| ASKA-SS | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | salermide | CTRP2 | 0.0120 | 200.0000 |
|
| ASKA-SS | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| ASKA-SS | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| ASKA-SS | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| ASKA-SS | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ASKA-SS | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ASKA-SS | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ASKA-SS | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ASKA-SS | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| ASKA-SS | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| ASKA-SS | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| ASKA-SS | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| ASKA-SS | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| ASKA-SS | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | StemRegenin 1 | CTRP2 | 0.0020 | 33.0000 |
|
| ASKA-SS | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| ASKA-SS | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| ASKA-SS | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| ASKA-SS | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| ASKA-SS | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| ASKA-SS | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| ASKA-SS | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| ASKA-SS | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| ASKA-SS | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| ASKA-SS | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| ASKA-SS | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| ASKA-SS | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC